Transitioning a digital health innovation from research to routine practice: Two-way texting for male circumcision follow-up in Zimbabwe.


Journal

PLOS digital health
ISSN: 2767-3170
Titre abrégé: PLOS Digit Health
Pays: United States
ID NLM: 9918335064206676

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 23 01 2022
accepted: 16 05 2022
entrez: 22 2 2023
pubmed: 23 2 2023
medline: 23 2 2023
Statut: epublish

Résumé

Adult medical male circumcision (MC) is safe: global notifiable adverse event (AE) rates average below 2.0%. With Zimbabwe's shortage of health care workers (HCWs) compounded by COVID-19 constraints, two-way text-based (2wT) MC follow-up may be advantageous over routinely scheduled in-person reviews. A 2019 randomized control trial (RCT) found 2wT to be safe and efficient for MC follow-up. As few digital health interventions successfully transition from RCT to scale, we detail the 2wT scale-up approach from RCT to routine MC practice comparing MC safety and efficiency outcomes. After the RCT, 2wT transitioned from a site-based (centralized) system to hub-and-spoke model for scale-up where one nurse triaged all 2wT patients, referring patients in need to their local clinic. No post-operative visits were required with 2wT. Routine patients were expected to attend at least one post-operative review. We compare 1) AEs and in-person visits between 2wT men from RCT and routine MC service delivery; and 2) 2wT-based and routine follow-up among adults during the 2wT scale-up period, January to October 2021. During scale-up period, 5084 of 17417 adult MC patients (29%) opted into 2wT. Of the 5084, 0.08% (95% CI: 0.03, 2.0) had an AE and 71.0% (95% CI: 69.7, 72.2) responded to ≥1 daily SMS, a significant decrease from the 1.9% AE rate (95% CI: 0.7, 3.6; p<0.001) and 92.5% response rate (95% CI: 89.0, 94.6; p<0.001) from 2wT RCT men. During scale-up, AE rates did not differ between routine (0.03%; 95% CI: 0.02, 0.08) and 2wT (p = 0.248) groups. Of 5084 2wT men, 630 (12.4%) received telehealth reassurance, wound care reminders, and hygiene advice via 2wT; 64 (19.7%) were referred for care of which 50% had visits. Similar to RCT outcomes, routine 2wT was safe and provided clear efficiency advantages over in-person follow-up. 2wT reduced unnecessary patient-provider contact for COVID-19 infection prevention. Rural network coverage, provider hesitancy, and the slow pace of MC guideline changes slowed 2wT expansion. However, immediate 2wT benefits for MC programs and potential benefits of 2wT-based telehealth for other health contexts outweigh limitations.

Identifiants

pubmed: 36812548
doi: 10.1371/journal.pdig.0000066
pii: PDIG-D-22-00019
pmc: PMC9931231
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000066

Informations de copyright

Copyright: © 2022 Marongwe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bull World Health Organ. 2012 Oct 1;90(10):773-81
pubmed: 23109745
Mhealth. 2020 Oct 05;6:43
pubmed: 33437839
Glob Policy. 2021 Mar 17;:
pubmed: 34230840
PLoS One. 2020 Oct 13;15(10):e0240425
pubmed: 33048977
PLoS Med. 2008 Jun 3;5(6):e116
pubmed: 18532873
Malar J. 2010 Sep 18;9:261
pubmed: 20849650
J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):16-23
pubmed: 31809358
JMIR Public Health Surveill. 2020 Apr 16;6(2):e18980
pubmed: 32297868
J Acquir Immune Defic Syndr. 2015 May 1;69(1):e13-23
pubmed: 25942466
J Glob Health. 2020 Dec;10(2):020396
pubmed: 33274059
AIDS. 2014 Sep 24;28(15):2307-12
pubmed: 25313586
J Int AIDS Soc. 2019 Jul;22(7):e25369
pubmed: 31368235
BMJ Open. 2018 Sep 1;8(8):e021835
pubmed: 30173159
J Int AIDS Soc. 2017 Feb 20;19(1):21394
pubmed: 28362066
PLoS One. 2019 Jun 10;14(6):e0218137
pubmed: 31181096
PLoS One. 2020 Sep 30;15(9):e0239915
pubmed: 32997710
J Int AIDS Soc. 2021 Sep;24 Suppl 5:e25789
pubmed: 34546643
BMJ Glob Health. 2021 Nov;6(11):
pubmed: 34815242
J Med Internet Res. 2019 Dec 20;21(12):e14994
pubmed: 31859679
BMC Health Serv Res. 2021 Apr 14;21(1):343
pubmed: 33853601
Global Health. 2018 Nov 3;14(1):103
pubmed: 30390686
Lancet Digit Health. 2019 May;1(1):e26-e34
pubmed: 31528850
PLoS One. 2020 Jun 16;15(6):e0233234
pubmed: 32544161
Am J Med. 2015 Oct;128(10):1139.e1-5
pubmed: 26087045
Global Health. 2017 Jul 31;13(1):49
pubmed: 28756767
Glob Health J. 2022 Jun;6(2):102-113
pubmed: 35282399
Curr HIV/AIDS Rep. 2018 Dec;15(6):414-422
pubmed: 30259258

Auteurs

Phiona Marongwe (P)

Zimbabwe Technical Training and Education Centre for Health (Zim-TTECH), Harare Zimbabwe.
Department of Global Health, University of Washington, Seattle, Washington, United States of America.

Beatrice Wasunna (B)

Medic, Nairobi, Kenya.

Jacqueline Gavera (J)

Zimbabwe Technical Training and Education Centre for Health (Zim-TTECH), Harare Zimbabwe.

Vernon Murenje (V)

Zimbabwe Technical Training and Education Centre for Health (Zim-TTECH), Harare Zimbabwe.

Farai Gwenzi (F)

Zimbabwe Technical Training and Education Centre for Health (Zim-TTECH), Harare Zimbabwe.

Joseph Hove (J)

Zimbabwe Association of Church related Hospitals (ZACH), Harare Zimbabwe.

Christine Mauhy (C)

Zimbabwe Community Health Intervention Research (ZiCHIRe), Harare Zimbabwe.

Sinokuthemba Xaba (S)

Ministry of Health and Child Care (MoHCC), Harare Zimbabwe.

Raymond Mugwanya (R)

Medic, Nairobi, Kenya.

Batsirai Makunike-Chikwinya (B)

Zimbabwe Technical Training and Education Centre for Health (Zim-TTECH), Harare Zimbabwe.

Tinashe Munyaradzi (T)

Zimbabwe Community Health Intervention Research (ZiCHIRe), Harare Zimbabwe.

Michael Korir (M)

Medic, Nairobi, Kenya.

Femi Oni (F)

Medic, Nairobi, Kenya.

Marrianne Holec (M)

International Training and Education Center for Health, Department of Global Health, University of Washington, Seattle, Washington, United States of America.

Vuyelwa Sidile-Chitimbire (V)

Zimbabwe Association of Church related Hospitals (ZACH), Harare Zimbabwe.

Mufuta Tshimanga (M)

Zimbabwe Community Health Intervention Research (ZiCHIRe), Harare Zimbabwe.

Isaac Holeman (I)

Medic, San Francisco, California, United States of America.
School of Medicine, University of Washington, Seattle, Washington, United States of America.

Scott Barnhart (S)

Department of Global Health, University of Washington, Seattle, Washington, United States of America.
International Training and Education Center for Health, Department of Global Health, University of Washington, Seattle, Washington, United States of America.
School of Medicine, University of Washington, Seattle, Washington, United States of America.

Caryl Feldacker (C)

International Training and Education Center for Health, Department of Global Health, University of Washington, Seattle, Washington, United States of America.
School of Medicine, University of Washington, Seattle, Washington, United States of America.

Classifications MeSH